Taxotere Patients Psychological Trauma Result in Lawsuits Against Sanofi-Aventis

Women suffering from permanent baldness can face a lifetime of psychological trauma resulting in physical damages

Friday, December 22, 2017 - It has been alleged in lawsuits that Sanofi-Aventis bribed physicians to prescribe their flagship chemotherapy drug Taxotere over safer, less toxic competitive brands. Plaintiffs claim that the company's marketing representatives overstated the drug's benefits and underplayed its toxicity in order to make the drug seem more effective in treating cancer. As a result of the company's marketing campaign, Taxotere became the leading anti-cancer chemotherapy drug in the US. Events subsequently showed, however, that the toxicity of Taxotere causes permanent, irreversible, and total hair loss, not "temporary hair loss" as they were told. Permanent hair loss affects roughly one in ten patients given the drug. Women are devastated by Taxotere's permanent hair loss side effect and outraged when they find out that high-level Sanofi executives may have known of the side effect yet failed to warn or advise them of their options.

Sanofi's defense of Taxotere permanent hair loss side effect is to downplay a woman's damages as being merely cosmetic and due to vanity. The psychological and emotional trauma that women experiencing permanent hair loss experience is all too real as deep emotional trauma manifests itself in uncontrollable physical agony. Many permanent hair loss victims suffer from depression so severe that they can not force themselves to leave their homes for the fear of being stared at and looked upon as inferior to other women who have hair. Some women report being so depressed that they cannot even get out of bed in the morning, let alone run a family or engage in their careers. When a woman's cancer is in remission, a person facing permanent baldness feel they are still sick with the disease for the rest of their lives and never really cured. Women have lost their jobs, their homes, their relationships, and even their families as they are unable to cope with the loss of self-esteem and self-confidence. Many have turned to powerful psychological drugs to cope with the daily, constant psychological pain they have. Some Taxotere hair loss women feel they have lost their femininity to Sanofi's deception and had they know of the permanence of their hair loss, would have chosen an alternative form of chemotherapy.

Every medical patient has the right to know the facts including any and all potential side effects of a drug they are about to be given. A woman is at her most vulnerable time when she receives a cancer diagnosis for the first time or again when cancer has returned. Sanofi may have preyed on this vulnerability when marketing executive told patients that they would only need to undergo chemotherapy treatment half as often and thus experience all of the other side effects of the drug half as often. Potential Taxotere patients were told that the drug's common side effects of nausea, lack of appetite and weight loss, headaches, lethargy and the myriad of other severe, adverse side effects would only have to be experienced half as often. When you add the benefit of fewer side effects to their vulnerability, it was easy to omit the fact that their hair loss could be permanent.

More Recent Taxotere Hair Loss Lawsuit News:

• Taxotere Alopecia Warning Limited to the Fine Print | 5/17/2019
• Women that have to undergo chemotherapy for the first time face great anxiety | 5/6/2019
• Taxotere Patients Denied Their Right To Make An Informed Decision | 4/24/2019
• Patients Must Be Made Aware Of Taxotere's Three Major Side Effects | 4/18/2019
• Women Are Angry Over Sanofi Failing To Warn About The Possibility of Permanent Hair Loss | 4/12/2019
• Women Undergoing Cancer Treatments Are Taking Better Care of Themselves to Limit Hair Loss | 4/5/2019
• Taxotere Permanent Hair Loss Has Devastating Psychological Implications For Patients | 3/25/2019
• Taxotere Causes Alopecia Which Can Be Psychologically Damaging | 3/20/2019
• Drug Makers Need To Write Clearer, More Descriptive Drug Warnings Starting With Taxotere | 3/18/2019
• Taxotere Lawsuits May Teach Doctors a Valuable Lesson | 3/13/2019
• Taxotere Permanent Baldness Warning | 4/30/2018
• Taxotere Chemotherapy and Permanent Hair Loss | 4/26/2018
• Sanofi Sales Representatives Oversold Taxotere | 4/24/2018
• Scientific Study Confirms Permanent Taxotere Hair Loss | 4/12/2018
• Chemotherapy Drug Side Effects | 4/9/2018
• Cancer Doctors Fail to Warn Patients | 4/4/2018
• Taxotere's Psychological Side Effects | 3/13/2018
• Permanent Hair Loss Can Lead to Depression | 3/6/2018
• A Woman's Hair is Linked to Their Feminity | 2/23/2018
• Studies Indicate Taxotere Causes Permanent Hair Loss | 2/14/2018
• Taxotere's Ambiguous Hair Loss Warning | 2/5/2018
• Permanent Hair Loss Makes the Fear of Growing Old All Too Real | 12/29/2017
• Thousands of Women File Taxotere Hair Loss Lawsuits | 12/27/2017
• Scientific Studies Point to Taxotere Hair Loss | 12/18/2017
• Cancer Patients Right to Make an Informed Decision | 12/13/2017
• How Women Think About Chemotherapy Hair Loss | 12/11/2017
• The Emotional Side Effects of Alopecia | 12/8/2017
• Taxotere May Cause Permanent Hair Loss | 12/4/2017
• Women Equate Baldness With Masculinity | 11/27/2017
• Symptoms of Permanent Hair Loss | 11/21/2017
• Taxotere's Warning May Have Come Too Late For Many | 11/15/2017
• Taxotere Benefits and Side Effects | 11/9/2017
• Women Were Not Given a Choice of Cancer Drugs | 11/1/2017
• The Impact of Permanent Hair Loss on Some Cancer Survivors | 9/29/2017
• The Emotional Side Effects of Permanent Hair Loss For Women Are All Too Real | 9/22/2017
• Taxotere is Highly Toxic and Causes Permanent Hair Loss | 9/15/2017
• 10-15 Percent of Cancer Patients Given Taxotere Develop Permanent Hair Loss | 9/8/2017
• Permanent Hair Loss From Taxotere is a Real Possibility | 9/1/2017
• Taxotere Permanent Hair Loss Lawsuits | 7/21/2017
• Permanent Hair Loss Caused by Taxotere | 6/26/2017
• Taxotere Warnings Now Include Permanent Hair Loss | 6/19/2017
• Taxotere Hair Loss Lawsuits Focus on Warning Label | 6/12/2017
• Permanent Hair Loss in Some Taxotere Users Delivers Secondary Blow to Cancer Patients | 6/5/2017

Lawyers for Taxotere Hair Loss Lawsuits

Onder, Shelton, O'Leary & Peterson, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. Onder, Shelton, O'Leary & Peterson has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.